Stay informed, stay ahead.
BridgeBio Pharma announced that its experimental medication for a rare genetic muscle disorder successfully met all primary and secondary targets in a late-stage study. The drug, aimed at treating Limb‑Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), a progressive condition affecting the muscles close to the hips and shoulders, demonstrated significant improvements in muscle markers compared to…
Medical equipment maker Revvity, Inc. raised its full-year 2025 profit outlook after reporting solid demand in its diagnostics business. During the third quarter, the company’s diagnostics unit generated $356.1 million in revenue, exceeding analyst expectations of $350.6 million. Overall quarterly revenue reached $699 million, just below the estimated $700.5 million. Adjusted earnings per share came…
New research suggests the human mind reaches its overall mental peak between ages 55 and 60. The study measured 16 psychological traits, including reasoning ability, memory, processing speed, and personality dimensions like conscientiousness and emotional stability. The findings challenge the common belief that brain power peaks in our 20s and 30s. While some abilities such…
UnitedHealth Group is attempting a comeback that has investors cautiously optimistic. The healthcare giant’s former CEO Stephen Hemsley returned to the helm in May 2025 after a sharp earnings miss and a leadership shake-up. Hemsley signed a three-year contract and personally bought around $25 million in company shares. His action signals confidence to investors who…
Millions of people worldwide, especially those managing conditions like diabetes, use artificial sweeteners believing they are a safe alternative to sugar. However, a study published in the journal Neurology suggests these substitutes may have a measurable negative impact on brain health. Key Study Finding The research, which focused on common sweeteners like aspartame, sucralose, erythritol,…
A major challenge to the global dominance of Novo Nordisk’s blockbuster diabetes and weight-loss drug, semaglutide (sold as Ozempic and Wegovy), has emerged from China. The Chinese pharmaceutical company Innovent Biologics has announced that its proprietary GLP-1 drug demonstrated superior effectiveness in treating Type 2 diabetes compared to Novo Nordisk’s semaglutide. The Basis of the…
The pharmaceutical giant Novartis is making a massive bet on the future of drug discovery. The company has announced an agreement to acquire Avidity Biosciences in a deal valued at $1.2 billion. Why Novartis is Paying $1.2 Billion Avidity Biosciences is a biotech company focused on developing a highly innovative class of drugs known as…
The release of new US dietary guidelines has been pushed back because of the ongoing government shutdown. The guidelines were expected before the end of October. Officials now say they will come in December. By law, they must be issued by 31 December. The US Department of Agriculture and the Department of Health and Human…
A leading UK charity, Maggie’s, is calling on the NHS to integrate exercise programmes into standard cancer care. It recommends options like yoga, tai chi and Nordic walking for the 386,000 people diagnosed with cancer in the UK each year. The charity argues that such physical activities improve survival rates, reduce tumour recurrence and relieve…
U.S. Health Secretary Robert F. Kennedy Jr. is set to recommend that Americans consume more saturated fats. His guidance would reverse decades of advice that urged limiting fats found in meat, dairy and certain oils. Health experts warn the change could lead to higher cholesterol and increased heart disease risk. American Heart Association nutrition specialist…
